Abiopharma

PTC COMPLETES DIVESTITURE OF KEPWARE AND THINGWORX BUSINESSES

Vivakor Receives Nasdaq Panel Approval for Path to Continued Listing, Upon Compliance by April 30, 2026

Canopy Growth Communication - Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada’s Leading Medical Cannabis Business By Revenue

monday.com Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law

SciSparc Notification (SPRC)

SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy

Camping World Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law

Osisko Development Announces Inclusion in the GDXJ

New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

Milestone Pharmaceuticals to Present Data on CARDAMYST™ (etripamil) Nasal Spray at the 2026 American College of Cardiology Annual Scientific Session

Millions Locked Out of Banking May Soon Find an Alternative at the Checkout Line. Alpha Cash Plans to Be That Alternative

New Form SCHEDULE 13G/A - Clearmind Medicine Inc. <b>Filed:</b> 2026-03-16 <b>AccNo:</b> 0001213900-26-028115 <b>Size:</b> 8 KB

Maris-Tech Receives Order from Governmental Defense Entity for Situational Awareness and Drone Video Payload Applications

Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation

Lucid kündigt erste Einzelhandelspartnerschaft in Europa an: Wackenhut startet Vertriebs- und Serviceaktivitäten in Deutschland USA - Deutsch USA - English USA - español